A Greener Future for Single-Use Disposables

Responsible Single-Use Biopharmaceutical Processing

Pharmaceutical companies are continuously streamlining processes to reduce their carbon footprint. The development of single-use biopharmaceutical processing was a step in the right direction, reducing the amount of water, chemicals, and energy required for cleaning validation.

Now, pharmaceutical companies are taking efficiency a step further.  In recent years, Biogen, Genentech, Johnson & Johnson, Novartis, and Patheon signed the American Business Act on Climate Pledge declaring their goals.  The BioXstream™ supports these ongoing initiatives, reducing your carbon footprint, energy and waste to landfill.

  • Reduction in CO2-heavy treatment services, including incineration
  • Reduction in waste transportation volume
  • Allows your single-use disposables to be recycled or re-purposed

Interested in BIOXstream™?

Just fill out some contact information and we'll be in touch.

Being Greener Delivers a ROI

The BIOXstream™ on-site treatment system offers a green shift in the way single-use biopharmaceutical waste is handled, treated and disposed of. With BioXstream™, waste can be treated before it ever leaves the pharmaceutical facility. This delivers a significant savings and ROI over current methods, and gives you the ability to maintain control over your waste, reducing risks and liability, while reducing the environmental impact:

  • Reduces treatment service costs
  • Reduces volume by up to 80%
  • Material rendered as common municipal waste
  • Eliminates the need for bleach rinse
  • Clean, green solution, allowing waste to be recycled

Enter Your Keyword